No Special Heart Risk With JAK Inhibitors, Study Finds Patients taking JAK inhibitors for RA experienced similar cardio
Tweet Content
No Special Heart Risk With JAK Inhibitors, Study Finds
Patients taking JAK inhibitors for RA experienced similar cardiovascular outcomes as those using the TNF blocker adalimumab (Humira), analysis of French national registry data indicated.
https://t.co/i0oUoTSmqF https://t.co/qrJMQbpqus
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off